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The existence of a novel receptor on human polymorphonucltxtr leukocytes (PMNLs) and monocytes was demonstrated, named soluble elastin 
peptide receptor. Soluble elastin peptides, like K-elastin, which are liberated from elastin fibres, can be found in the sera, and they possess everal 
biological activities such as chemotaxis. Studying the effects of elastin peptides on leukocytes, it was found that: (i) the elastin peptide stimulates 
the oxidative burst, the intracellular free Ca2+ elevation through a specific receptor; and (ii) in the signal transduction mechanism of this elastin 
peptide receptor, the ph~phatidy~nositol breakdown is involved. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Interaction between cells and macromolecules of the 
extracellular matrix is critically important on one hand 
for the maintenance of physiological cellular structure 
and functions, and the other hand in pathogenesis of 
several diseases such as emphysema [3,4] and 
atherosclerosis [5]. During these last few years it 
became evident that specific interactions exist between 
different cell types (e.g. smooth muscle cells, 
fibroblasts and leukocytes) and the degradation pro- 
ducts of this matrix [1,2]. 
During the injury of elastic fibres, soluble elastin 
peptides are liberated, and these liberated elastin pep- 
tides are present in the circulation [4,6]. It was 
demonstrated that soluble elastin peptides (such as K- 
elastin, KE) possess important biological activities. 
They are chemotactic for fibroblasts j7] and for 
monocytes 181, induce intr~ysosomal enzyme release 
from monocytes 191, and stimulate the 45Ca uptake into 
monocytes, fibroblasts and smooth muscle cells [IO]. 
According to the above-mentioned effects of soluble 
elastin peptides the aim of our present work was: (i) to 
study the effects of soluble elastin peptide, KE, on 
human grauulocytes; (ii) to demonstrate the existence 
of soluble elastin specific receptors on leukocytes; and 
(iii) to determine the signal transduction mechanism of 
these elastin peptide receptors. 
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2. I. Patienfs 
Cells were obtained from 15 healthy young (c 35 years) subjects. 
All of them gave fully informed consent and were volunteers. The 
selection of these persons was based on the criteria of good physical 
and mental health confirmed by careful clinical and laboratory in- 
vestigations. 
2.2. Cell preparation 
Polymorphonuclear leukocytes (PMNLs) and monocytes were 
separated by Ficoll-Hypaque density gradient centrifugation accor- 
ding to the method of Boyurn Ill]. The cells were at least 95% viable 
judged by Trypan blue exclusion. 
2.3. Materias 
Superoxide dismutase (SOD), Cytochrome C, FMLP were from 
Sigma, Quin 2/AM was purchased from Calbiochem, Pertussis toxin 
(PT) was from List Biological Laboratories, and myo(2-[‘H])inositol 
was from Amersham (spec. act.: 614 GBq/mmol). 
This was prepared from bovine ligamenturn nuchae elastin by 
alkaline hydrolysis in ethanol [ 121. The prepared KE was tritiated with 
NaB3H4 according to the method of Bieger and Scheele [13], spec. 
act.: 6.66.106 cpm/pg. 
2.5. Experimental conditions 
The cells were resuspended in M 199 medium (Gibco) and for 
measurements in HBSS, with or without 1 mM calcium. The incuba- 
tions were carried out in a CO2 incubator, at 37°C. The preincubation 
time with 500 ng/ml PT was 2 h. 
2.6. 0;production 
This was measured by SOD sensitive reduction of Cytochrome C 
u41. 
2.7. rntracetiutar f ee C42 + 
The PMNLs were loaded with Quin 2/AM according to the method 
of Tsien et al. [15]. The measurements were carried out as published 
elsewhere [161. 
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2.8. Myo(2-tHj)inositol loading 
To 10’ cells/ml, 20 &i/ml inositol in M 199 medium containing 
2% FCS was added. After the appropriate incubation time (2 h, at 
37”C), the cells were washed with warm HBSS. After adding KE in 1 
fig/ml concentration to the cells, the reaction was stopped with cold 
TCA at a final concentration of 6%. The lipids were extracted with 
chloroform:methanol:HCl (5O:lOO:l v/v/v), the TCA was removed 
by ethylether extraction and the neutralised aqueous phase was used 
for inositol phosphate (IP) determination. 
2.9. separation of inositol phosphates 
The inositol phosphates were separated on DOWEX 1 x 8 ionex- 
changer (formate form) with increasing concentration of ammonium 
formate [ 171. The activity of samples was measured in a liquid scintil- 
lation counter. 
2.10. ~H]ei~ti~ bidding assay 
This was based on the method of Smith and Sestili [la]. The cefls 
were incubated with labelled KE in the presence and absence of the ex- 
cess of unlabelled KE as described in the figure legends. After incuba- 
tion (2 h, at 22”(Z), the cells were harvested, and the activity of 
samples was measured in a liquid scintillation counter. 
3. RESULTS 
It is well known that one of the obvious signs of 
PMNL stimulation is the activation of the respiratory 
burst, therefore, the effect of KE on O~production was 
studied. In all of our experiments, the FMLP was used 
as a positive control. It was found that KE stimulates 
the 0;production in PMNLs in a PT-sensitive manner 
(fig. 1). 
k$&z4 IGGj 
FMLP 
Fig. 1. Effect of pertussis toxin, PT ( q ), preincubation on K-elastin, 
KE (m)-induced Ogproduction in PMNLs. The last column shows the 
results with the positive control FMLP (0). Bach value represents the 
mean k SD of ten determinations. 
Previously, it was demonstrated that KE stimulates 
the calcium influx in monocytes, fibroblasts and 
smooth muscle cells [IO], therefore we were interested 
to investigate the effect of KE on intraceilular free 
Cazf levels. It was found that KE stimulates the in- 
tracellular free Ca2 + elevation (fig.2a), and this KE- 
stimulated intracellular free Ca2 + mobilization can be 
inhibited by PT preincubation (Fig.2b). The role of 
both extra-, and intracellular calcium pools, in KE- 
induced intracellular free Ca2’ elevation, was confirm- 
ed by measuring the effect of KE on intracellular free 
Ca2 + in the absence of extracellular Ca* ’ . It can be 
seen in fig.2c that the KE-induced intracellular free 
Ca2 + elevation decreases 25% in the absence of ex- 
tracellular Ca2 + . 
In our experiments, the next step was the determina- 
tion of [3H]elastin binding specificity. The saturability 
of [‘Hlelastin binding to human PMNLs and to 
monocytes can be seen in fig.3. The results of the Scat- 
chard analysis are shown in the insert of the figure, the 
calculated & = 0.18 nM for PMNLs, and & = 0.47 nM 
for monocytes. 
Because PT inhibits the KE-induced 02 production 
and intracellular free Ca2+ mobilisation, the effect of 
PT preincubation was also studied on t3H)elastin bin- 
ding (fig.4). It was found that PT preincubation could 
not alter the binding of [‘Hlelastin to the receptor. 
r- 
a. [&]a = 1mM 
c. [Ca*']e =O mM 
F 
t 
1.0 rg/mt KE 2 min 
Fig.2. Effect of PT (b) and the absence of extracellular calcium (c) on 
K-elastin-induced intracellular free calcium mobilization (a). The 
dotted line in this figure shows the FMLP-induct calcium elevation 
(a). 
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Fig.3. Saturability of [‘HJelastin binding to PMNLs (*) and monocytes (+), at 22°C. Cells were incubated with increasing concentrations 
of [‘Hlelastin in the presence and absence of unlabelled elastin (10e6 M), the amount of specifically bound KE was calculated from these data. 
Each experiment was done in triplicate. Scatchard analysis of the binding data is shown in the insert. 
From our present results it could be supposed that the 
elastin peptide receptor belongs to the family of calcium 
mobilizing receptors. It is well known that the 
phosphatidylinositol breakdown plays an important 
role in the signal transduction mechanism of calcium 
mobilizing receptors, therefore the effect of KE on 
inositol phosphates formation was studied. In fig.5 it 
can be seen that KE induces inositol phosphate forma- 
tion both in PMNLs and in monocytes. 
Finally, the effect of PT preincubation on KE- 
induced inositol phosphate formation was examined. It 
- PT 
Fig.4. Effect of pertussis toxin, PT (a), on the binding of [‘Hlelastin 
(0), 0.2 nM, to human PMNLs. Each experiment was done in 
triplicate. 
was found that PT inhibits the KE-stimulated inositol 
phosphate formation in human leukocytes (fig.6). 
a., PMNLs 
I 
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Fig.5. The K-elastin-induced inositol phosphate formation in PMNLs 
(a) and monocytes (b). Each value represents the mean f SD of three 
independent experiments. The insert shows the positive control, 
FMLP-induced inositol phosphate formation in PMNLs after 15-s 
incubation. 
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Fig.6. Effect of PT (b) preincubation on K-elastin-induced (a) inositol 
phosphate formation after 15 s incubation. The ruffled part of 
columns shows the inositol phosphate level in control cells. Each 
value represents the mean f SD of three experiments. 
4. DISCUSSION 
It is well known that atherosclerosis a very frequent 
disease and many efforts have been made to elucidate 
its pathomechanism. During the atherosclerotic plaque 
formation, the injury of elastic fibres is occurring and 
the consequence of this injury is the liberation of solu- 
ble elastin peptides. We think that the study of the ef- 
fects of elastin peptides on leukocytes is important, 
because leukocytes interact with soluble elastin peptides 
in physiological circumstances as soluble elastin pep- 
tides are present in the sera [4,19]. 
From our present results it can be concluded that 
soluble elastin peptides, such as K-elastin, can stimulate 
human leukocytes, i.e. they induce the 02production, 
intracellular free calcium mobilization. We were able to 
demonstrate the presence of elastin peptide specific 
receptors on human PMNLs and monocytes, with the 
binding efficiency Kd = 0.18 nM for PMNLs and 
& = 0.47 nM for monocytes. It was also demonstrated 
that the phosphatidylinositol breakdown is involved in 
the signal transduction mechanism of soluble elastin 
peptide receptor. The receptor is coupled to the 
phospholipase C through a PT-sensitive GTP binding G 
protein. This contention is based on the following fin- 
dings: the PT inhibits the KE-stimulated inositol 
phosphate formation, 02production, and intracellular 
free calcium mobilization, but could not alter the bin- 
ding of [3H]elastin to the cells. 
Although the role of soluble elastin peptides liberated 
from the elastic fibres in the pathogenesis of 
atherosclerosis is not yet elucidated, we think that the 
results of our investigation to demonstrate the presence 
of elastin peptide receptor and its signal transduction 
mechanism on cells actively participating in the 
atherosclerotic process [20] will give some new informa- 
tion to atherosclerosis research. 
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